Petredis Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Buy
11,273
+22
+0.2% +$22.5K 0.91% 26
2026
Q1
$10.3M Sell
11,251
-105
-0.9% -$106K 0.85% 30
2025
Q4
$12.2M Sell
11,356
-130
-1% -$124K 0.96% 24
2025
Q3
$8.76M Sell
11,486
-120
-1% -$89.3K 0.7% 31
2025
Q2
$9.05M Buy
11,606
+244
+2% +$190K 0.79% 31
2025
Q1
$9.38M Buy
11,362
+139
+1% +$116K 0.98% 23
2024
Q4
$8.66M Sell
11,223
-219
-2% -$181K 0.9% 25
2024
Q3
$10.1M Buy
11,442
+29
+0.3% +$26.1K 1.08% 24
2024
Q2
$10.3M Buy
11,413
+40
+0.4% +$32K 1.16% 17
2024
Q1
$8.85M Buy
11,373
+316
+3% +$225K 1.06% 23
2023
Q4
$6.45M Sell
11,057
-356
-3% -$208K 0.85% 29
2023
Q3
$6.13M Buy
11,413
+19
+0.2% +$9.79K 0.87% 28
2023
Q2
$5.34M Sell
11,394
-43
-0.4% -$18K 0.73% 33
2023
Q1
$3.93M Buy
11,437
+121
+1% +$40.8K 0.61% 46
2022
Q4
$4.14M Buy
+11,316
New +$4.01M 0.75% 42

Other funds holding LLY

Petredis Investment Advisors's LLY Position: Q2 2026 in Review

Petredis Investment Advisors increased its Eli Lilly (LLY) stake by 0.2% in Q2 2026, buying an estimated $22.5K and bringing the position to 11,273 shares worth $13.5M. The position accounts for 0.91% of the portfolio, ranked #26.

Petredis Investment Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Petredis Investment Advisors held 11,273 shares of Eli Lilly worth $13.5M as of Q2 2026.
  • Petredis Investment Advisors bought 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.91% of Petredis Investment Advisors's portfolio in Q2 2026, its #26 holding.
  • Petredis Investment Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.